Inside BARDA’s multibillion-dollar effort to fund long-shot biotechs for Covid

In 2023, Vaxart halted work on its oral vaccine for Covid-19, and didn’t even have enough money to finish 2024.

Now, the US government is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

How race became ubiquitous in medical decision-making tools

This is Part 2 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it’s so difficult to change them. It

September 4, 2024

UCL researchers develop UK’s first national menopause education program

Details of two new courses to help individuals before and during the menopause have been published as part of the launch of the UK’s first

September 14, 2024

Corrected: Emergent sells Baltimore facility for $30M

Emergent BioSolutions is selling off a Baltimore manufacturing site for $30 million to Bora Pharmaceuticals. “The decision to sell our Camden manufacturing facility is aligned

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.